Kestra Medical Technologi...

23.95
0.12 (0.50%)
At close: Apr 15, 2025, 3:59 PM
24.13
0.75%
After-hours: Apr 15, 2025, 04:12 PM EDT

Company Description

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.

It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.

The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA).

The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes.

The company was founded in 2014 and is based in Kirkland, Washington.

Kestra Medical Technologies Ltd. Common Stock
Kestra Medical Technologies Ltd. Common Stock logo
Country United States
IPO Date Mar 6, 2025
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 300
CEO Brian Webster

Contact Details

Address:
3933 Lake Washington Blvd NE
Kirkland, Washington
United States
Website https://kestramedical.com

Stock Details

Ticker Symbol KMTS
Exchange NASDAQ
Fiscal Year May - April
Reporting Currency USD
CIK Code 0001877184
CUSIP Number n/a
ISIN Number BMG524411052
Employer ID 00-0000000
SIC Code 3841

Key Executives

Name Position
Brian Webster Founder, President, Chief Executive Officer & Director
Gordon Teddy Chief Information Officer
Vaseem Mahboob Chief Financial Officer
Alfred J. Ford Jr. Chief Commercial Officer
Debra Schotz Senior Vice President of Marketing
Jeffrey Laub Senior Vice President of Operations
Neil Bhalodkar Vice President of Investor Relations
Phillip D. Foshee Jr. Senior Vice President of Research & Development
Traci S. Umberger Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director

Latest SEC Filings

Date Type Title
Apr 14, 2025 8-K Current Report
Feb 04, 2025 DRS/A [Amend] Filing
Jan 17, 2025 DRS/A [Amend] Filing
Dec 11, 2024 DRS/A [Amend] Filing
Nov 23, 2021 DRS/A [Amend] Filing
Aug 25, 2021 DRS Filing